This website uses cookies. By continuing to browse this website you are agreeing to our use of cookies. Find out more by reading our privacy policy. Read more
News releases
Download
Full announcementNovo Nordisk A/S : Status regarding Novo Nordisk's holding of its own shares (31 March 2012)
In continuation of the company's announcements dated 2 November 2011 and 2 February 2012 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S (NYSE: NVO) and its wholly-owned affiliates on 31 March 2012 owned 27,329,627 of its own B shares of DKK 1, corresponding to a total nominal value of DKK 27,329,627 or 4.71% of the total share capital.
| Media: | Investors: |
| Anne Margrethe Hauge | Klaus Bülow Davidsen |
| Tel: (+45) 4442 3450 | Tel: (+45) 4442 3176 |
| amhg@novonordisk.com | klda@novonordisk.com |
| Frank Daniel Mersebach | |
| Tel: (+45) 4442 0604 | |
| fdni@novonordisk.com | |
| Lars Borup Jacobsen | |
| Tel: (+45) 3075 3479 | |
| lbpj@novonordisk.com | |
| In North America: | |
| Ken Inchausti | Jannick Lindegaard |
| Tel: (+1) 609 514 8316 | Tel: (+1) 609 786 4575 |
| kiau@novonordisk.com | jlis@novonordisk.com |
Company Announcement no 21 / 2012








